Haemophilus influenza (Hib) diseases

Haemophilus influenzae type b (Hib) is estimated to cause millions of cases of serious disease worldwide and hundreds of thousands of deaths each year among young children. The main clinical manifestations of invasive Hib infections include severe pneumonia and meningitis. Hib vaccines are the only public health tool capable of preventing the majority of cases of serious Hib disease; and in view of their demonstrated safety and efficacy, WHO recommends including conjugate Hib vaccines in all routine infant immunization programmes.

Top story

Slovakia raises awareness about vaccination

A new publication on vaccination in Slovakia and the European Union was launched at the start of the Slovak Presidency of the Council of the European Union this month to educate experts, health workers and the general public on the importance of vaccination in preventing serious diseases.

WHO_Europe_VPI twitter feed

European Immunization Week

Each year in April, EIW promotes the core message that the immunization of every child is vital to prevent diseases and protect life. The goal of the region-wide campaign is to increase vaccination coverage by raising awareness of the importance of immunization. EIW 2016 was celebrated on 24–30 April.

This year's campaign

Data and statistics

Although the age-specific incidence and type of disease vary in different parts of the world, statistics show that about 80% of invasive Hib disease occurs before the age of 5 in all locations.

More data and statistics

Immunization advocacy library

Tools for immunization programme managers and other stakeholders to advocate for prioritization of immunization in political agendas and public health budgets

Full library

Immunize Europe Forum

WHO/Europe is proud to announce the launch of a new online resource for the immunization community

Visit the Forum